Hormone replacement therapy decreases the risk of tinnitus in menopausal women: a nationwide study.
We examined the medical records of menopausal women aged between 45 and 79 years from Taiwan's National Health Insurance Research Database of records between 1 January 2000 and 31 December 2010 to establish matched cohorts (13,920 HRT users and 41,760 nonusers). The incidence of tinnitus in HRT users and nonusers were matched 1:3 based on propensity-score matching over this ten year period. The Cox regression hazard model was used to identify risk factors of tinnitus, and results indicate that a significantly lower percentage of HRT users (P = 0.017) developed tinnitus in comparison with nonusers (0.43%, 60/13, 920 vs. 0.59%, 246/41, 760). Using Cox regressions analysis after adjustments for age and other variables (adjusted hazard ratio: 0.505 (95% confidence interval, 0.342-0.756)), we were also able to show that HRT users appeared to have a reduced risk of developing tinnitus in comparison with nonusers. Based on our observation of the lower incidence of tinnitus among HRT users in this cohort, we speculate that HRT may have provided potential benefits on the management and prevention of tinnitus among menopausal women. PMID: 29731984 [PubMed]
Anxiety is a common symptom of menopause but it can often be overlooked. Dr Meg Arroll, a psychologist and women's health expert, reveals ways to tackle anxiety during this time.
ConclusionWe believe the etiology of meningioma in our patients started at childhood and progress to this giant status. We therefore suggest that neurosurgeon's screen children early to detect meningiomas before they advance into giant stages. Two years follow-up after surgery showed no tumor recurrence.
Early onset menopause in women with or without diabetes may increase their risk of an early death, according to research published inMenopause.News Medical
Publication date: Available online 16 October 2018Source: Journal of Theoretical BiologyAuthor(s): Peter S. Kim, John S. McQueen, Kristen HawkesAbstractGreat apes, the other living members of our hominid family, become decrepit before the age of forty and rarely outlive their fertile years. In contrast, women – even in high mortality hunter-gatherer populations – usually remain healthy and productive well beyond menopause. The grandmother hypothesis aims to account for the evolution of this distinctive feature of human life history. Our previous mathematical simulations of that hypothesis fixed the end of femal...
AbstractPurpose of ReviewPatients with chronic kidney disease (CKD) have a greatly increased fracture risk compared with the general population. Gonadal hormones have an important influence on bone mineral density (BMD) and fracture risk, and hormone therapies can significantly improve these outcomes. Gonadal dysfunction is a frequent finding in patients with CKD; yet, little is known about the impact of gonadal hormones in the pathogenesis and treatment of bone health in patients with CKD. This systematic review and meta-analysis aimed to examine the effects of gonadal hormones and hormone therapies on bone outcomes in me...
ConclusionCompared with women without adenomyosis, those with histopathologically proven adenomyosis were less likely to report persistent pain following hysterectomy. Retention of the cervix does not appear to increase the risk of symptom persistence or postprocedure patient satisfaction.
(The North American Menopause Society (NAMS)) Only in science fiction novels can scientists predict people's lifespans. However, researchers have advanced the understanding of those risk factors that adversely affect mortality rates. A new study concludes that women who experienced early menopause lived shorter lives and spent fewer years without diabetes than women who experienced normal or late menopause. Study results are published online in Menopause, the journal of The North American Menopause Society (NAMS).
This article is protected by copyright. All rights reserved.
Systematic reviews and meta‐analyses represent the uppermost ladders in the hierarchy of evidence. Systematic reviews/meta‐analyses suggest preliminary or satisfactory clinical evidence for agnus castus (Vitex agnus castus) for premenstrual complaints, flaxseed (Linum usitatissimum) for hypertension, feverfew (Tanacetum partenium) for migraine prevention, ginger (Zingiber officinalis) for pregnancy‐induced nausea, ginseng (Panax ginseng) for improving fasting glucose levels as well as phytoestrogens and St John's wort (Hypericum perforatum) for the relief of some symptoms in menopause. However, firm conclusions of ef...